Detalhe da pesquisa
1.
Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.
Int J Mol Sci
; 24(24)2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38139172
2.
DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer.
Cancers (Basel)
; 15(5)2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900421
3.
DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.
Sci Rep
; 10(1): 9239, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514046